Ovestin (Estriol)

Ovestin is an estrogen therapy that acts on hormonal pathways involved in menopause and related conditions.

• Menopause symptom relief: Improves vasomotor symptoms such as hot flashes and night sweats.
• Vaginal atrophy: Restores vaginal epithelium and reduces dryness.
• Osteoporosis prevention: Contributes to bone density maintenance in postmenopausal women.

• Estradiol binds to estrogen receptors (ERα and ER β) in target tissues, initiating transcription of genes that regulate reproductive, metabolic and skeletal functions. The receptor‑mediated activation modulates cellular proliferation, collagen synthesis and calcium homeostasis, producing systemic estrogenic effects.

Adverse reactions to estradiol‑containing products vary with dose and route of administration.

Common Side Effects

• Nausea: Mild to moderate gastrointestinal upset.
• Breast tenderness: Localized discomfort or swelling.
• Headache: Tension‑type or migraine‑like pain.
• Fluid retention: Mild peripheral edema.
• Mood changes: Irritability or mild depressive symptoms.

Serious or Rare Side Effects

• Thromboembolic events: Deep‑vein thrombosis or pulmonary embolism.
• Stroke: Ischemic or hemorrhagic cerebrovascular accident.
• Hepatotoxicity: Elevated liver enzymes or jaundice.
• Hormone‑dependent cancer progression: Potential stimulation of breast or endometrial tumors.
• Severe allergic reaction: Anaphylaxis or angio‑edema.

When prescribing estradiol products, clinicians should consider several safety aspects.

• Cardiovascular risk assessment: Evaluate history of thromboembolism, stroke, or myocardial infarction.
• Cancer screening: Perform regular breast and endometrial examinations.
• Liver function monitoring: Check enzymes in patients with hepatic impairment.
• Hormone‑sensitive conditions: Use caution in women with a history of estrogen‑dependent tumors.
• Drug‑interaction review: Assess concomitant medications that affect coagulation or hormone metabolism.
• Store at ambient temperature: Keep below 25°C in the original packaging, protected from moisture.

Estradiol may interact with a range of medicines that alter its metabolism or increase clotting risk.

Major Interactions (Avoid)

• Warfarin: Potentiates anticoagulant effect and raises bleeding risk.
• Combined oral contraceptives: Increases estrogen load, heightening thrombotic potential.
• GnRH agonists: May blunt therapeutic response and alter hormone levels.

Moderate Interactions (Monitor Closely)

• Antifungal azoles (ketoconazole, itraconazole): Reduce estradiol clearance.
• Antiretroviral protease inhibitors: May increase estradiol plasma concentrations.
• Selective serotonin reuptake inhibitors (SSRIs): Can affect estradiol metabolism and mood‑related side effects.